Liposomal daunorubicin (Daunoxome) in the treatment of acute lymphocytic leukemia (ALL).

被引：0
|
作者：
Baccarani, M [1 ]
Russo, D [1 ]
Fanin, R [1 ]
Michieli, M [1 ]
机构：
[1] Univ Hosp, Div Hematol, Udine, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3110
引用
收藏
页码：720A / 720A
页数：1
相关论文
共 50 条
  • [21] DAUNORUBICIN (DNR) CARDIAC TOXICITY IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA (ALL)
    HALAZUN, JF
    WAGNER, HR
    GAETA, JF
    SINKS, LF
    CANCER CHEMOTHERAPY REPORTS PART 1, 1973, 57 (01): : 106 - 106
  • [22] Early evaluation of liposomal daunorubicin (DaunoXome®, Nexstar) in the treatment of relapsed and refractory lymphoma
    Deborah S. Richardson
    Stephen M. Kelsey
    Stephen A. Johnson
    Mary Tighe
    James D. Cavenagh
    Adrian C. Newland
    Investigational New Drugs, 1997, 15 : 247 - 253
  • [23] Liposomal daunorubicin (DaunoXome®) as part of treatment for Hodgkin disease during pregnancy.
    Dulley, FL
    Saboya, R
    Macedo, MCMA
    Pallotta, RS
    Silva, RL
    Jamra, M
    Chamone, DAF
    BLOOD, 1998, 92 (10) : 236B - 236B
  • [24] Liposomal, daunorubicin (daunoxome, DNX) has minimal cardiotoxicity in patients with prior anthracycline therapy for acute myeloid leukemia (AML).
    Cortes, JE
    Fassas, A
    Anagnostopoulous, A
    Gacos, E
    Kaloyannidis, P
    Kantarjian, H
    Giles, FJ
    BLOOD, 1999, 94 (10) : 508A - 508A
  • [25] Early evaluation of liposomal daunorubicin (DaunoXome(R), Nexstar) in the treatment of relapsed and refractory lymphoma
    Richardson, DS
    Kelsey, SM
    Johnson, SA
    Tighe, M
    Cavenagh, JD
    Newland, AC
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (03) : 247 - 253
  • [26] Liposomal daunorubicin (DaunoXome) in children with recurrent or progressive brain tumors
    Lippens, RJJ
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1999, 16 (02) : 131 - 139
  • [27] Dose-escalating study of DaunoXome, liposomal daunorubicin, in the treatment of metastic breast cancer
    Thomas, A
    Shields, F
    Wells-Jordan, P
    Lloyd, D
    Hubbard, A
    Steward, WP
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 1999, 80 : 103 - 103
  • [28] A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemia
    Goemans, Bianca F.
    Zwaan, Christian M.
    Reinhardt, Dirk
    Gibson, Brenda E. S.
    Hahlen, K.
    Kaspers, Gert Jan L.
    HAEMATOLOGICA, 2006, 91 (11) : 1573 - 1574
  • [29] PHASE-I AND PHARMACOLOGICAL STUDY OF LIPOSOMAL DAUNORUBICIN (DAUNOXOME)
    GUAGLIANONE, P
    CHAN, K
    DELAFLORWEISS, E
    HANISCH, R
    JEFFERS, S
    SHARMA, D
    MUGGIA, F
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (02) : 103 - 110
  • [30] Safety of high-dose liposomal daunorubicin (DaunoXome) for refractory or relapsed acute myeloblastic leukaemia
    Fassas, A
    Buffels, R
    Kaloyannidis, P
    Anagnostopoulos, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (01) : 161 - 163
12345